close
MENU
How to guide
How to guide
Home
NBR Marketplace
The NBR List
NBR Video

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

Podcasts Audio Articles Entrepreneurs Your Business Beehive Banter Morning Brew Toil & Trouble NZ Aviation News Back Issues Market Outlook Dollars & Sense Private Bin Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Shoeshine
10 mins to read
3

Winners and losers in NZ’s medicinal cannabis market

ANALYSIS: Why have some have crashed and burned, while others hung in there?

WATCH: NBR Senior journalist Fiona Rotherham speaks with Simon Shepherd.

Fiona Rotherham Mon, 10 Mar 2025

Elizabeth Plant says she could write a book about her experiences in the medicinal cannabis market after being involved in two ventures that went under and one that went into voluntary administration.

Plant is the former CEO of listed Greenfern Industries which was placed in receivership by a

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

NZ$399.00 / yearly

Offer ends March 31st

Smartphone Only Annual Subscription

NZ$299.00 / yearly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Subscription

NZ$29.95 / monthly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Mon, 10 Mar 2025
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
medicinal cannabis Greenfern Industries Elizabeth Plant Puro Helius Therapeutics
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment
1

Rua Bioscience boosts revenue, needs to raise more funds
Investment
2

Listed medicinal cannabis firm Greenfern in receivership
General Business

Medical Kiwi administrators to recommend liquidation

General Business

MedCan grower Puro inks major distribution deal in Australia
Shoeshine

Has Greenfern Industries turned over a new leaf?
The NBR Podcast

Podcast #13: Medicinal cannabis – the green gold rush?
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment
1

Rua Bioscience boosts revenue, needs to raise more funds
Investment
2

Listed medicinal cannabis firm Greenfern in receivership
General Business

Medical Kiwi administrators to recommend liquidation

General Business

MedCan grower Puro inks major distribution deal in Australia
Shoeshine

Has Greenfern Industries turned over a new leaf?
The NBR Podcast

Podcast #13: Medicinal cannabis – the green gold rush?
Winners and losers in NZ’s medicinal cannabis market
Shoeshine,
108172
true
Subscribe Login